Massachusetts Financial Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23B | Sell |
5,610,330
-953,928
| -15% | -$212M | 0.41% | 68 |
|
|
2025
Q4 | $1.5B | Sell |
6,564,258
-1,797,129
| -21% | -$409M | 0.48% | 59 |
|
|
2025
Q3 | $1.94B | Sell |
8,361,387
-258,984
| -3% | -$52.7M | 0.6% | 41 |
|
|
2025
Q2 | $1.6B | Sell |
8,620,371
-229,875
| -3% | -$42.7M | 0.51% | 57 |
|
|
2025
Q1 | $1.85B | Sell |
8,850,246
-197,962
| -2% | -$38.5M | 0.62% | 41 |
|
|
2024
Q4 | $1.61B | Sell |
9,048,208
-282,571
| -3% | -$52M | 0.51% | 52 |
|
|
2024
Q3 | $1.84B | Buy |
9,330,779
+373,802
| +4% | +$69.8M | 0.55% | 50 |
|
|
2024
Q2 | $1.54B | Buy |
8,956,977
+273,429
| +3% | +$45.3M | 0.47% | 58 |
|
|
2024
Q1 | $1.58B | Buy |
8,683,548
+260,935
| +3% | +$45M | 0.47% | 58 |
|
|
2023
Q4 | $1.31B | Buy |
8,422,613
+2,390,239
| +40% | +$348M | 0.42% | 72 |
|
|
2023
Q3 | $899M | Buy |
6,032,374
+6,012,281
| +29,922% | +$883M | 0.31% | 95 |
|
|
2023
Q2 | $2.71M | Sell |
20,093
-8,353
| -29% | -$1.22M | ﹤0.01% | 680 |
|
|
2023
Q1 | $4.53M | Buy |
28,446
+11,681
| +70% | +$1.79M | ﹤0.01% | 653 |
|
|
2022
Q4 | $2.71M | Buy |
16,765
+304
| +2% | +$46.6K | ﹤0.01% | 699 |
|
|
2022
Q3 | $2.21M | Sell |
16,461
-12,130
| -42% | -$1.74M | ﹤0.01% | 710 |
|
|
2022
Q2 | $4.38M | Buy |
+28,591
| New | +$4.37M | ﹤0.01% | 661 |
|
|
2022
Q1 | – | Sell |
-21,073
| Closed | -$2.85M | – | 858 |
|
|
2021
Q4 | $2.85M | Sell |
21,073
-20,620
| -49% | -$2.44M | ﹤0.01% | 738 |
|
|
2021
Q3 | $4.5M | Buy |
41,693
+758
| +2% | +$86.6K | ﹤0.01% | 717 |
|
|
2021
Q2 | $4.61M | Sell |
40,935
-1,544
| -4% | -$174K | ﹤0.01% | 715 |
|
|
2021
Q1 | $4.6M | Sell |
42,479
-10,512
| -20% | -$1.12M | ﹤0.01% | 702 |
|
|
2020
Q4 | $5.68M | Sell |
52,991
-183,492
| -78% | -$17.6M | ﹤0.01% | 673 |
|
|
2020
Q3 | $20.7M | Sell |
236,483
-105,008
| -31% | -$9.89M | 0.01% | 567 |
|
|
2020
Q2 | $33.5M | Buy |
341,491
+60,318
| +21% | +$5.31M | 0.01% | 483 |
|
|
2020
Q1 | $21.4M | Buy |
281,173
+87,593
| +45% | +$7.46M | 0.01% | 503 |
|
|
2019
Q4 | $17.1M | Buy |
193,580
+39,269
| +25% | +$3.26M | 0.01% | 551 |
|
|
2019
Q3 | $11.7M | Buy |
+154,311
| New | +$10.6M | ﹤0.01% | 593 |
|
|
2016
Q3 | – | Sell |
-43,180
| Closed | -$2.67M | – | 858 |
|
|
2016
Q2 | $2.67M | Sell |
43,180
-7
| -0% | -$427 | ﹤0.01% | 698 |
|
|
2016
Q1 | $2.47M | Hold |
43,187
| – | – | ﹤0.01% | 693 |
|
|
2015
Q4 | $2.56M | Sell |
43,187
-10,862
| -20% | -$626K | ﹤0.01% | 702 |
|
|
2015
Q3 | $2.94M | Sell |
54,049
-4,545
| -8% | -$296K | ﹤0.01% | 703 |
|
|
2015
Q2 | $3.94M | Sell |
58,594
-11,314
| -16% | -$739K | ﹤0.01% | 694 |
|
|
2015
Q1 | $4.09M | Sell |
69,908
-5,090,316
| -99% | -$308M | ﹤0.01% | 698 |
|
|
2014
Q4 | $338M | Buy |
5,160,224
+2,956,724
| +134% | +$186M | 0.17% | 135 |
|
|
2014
Q3 | $127M | Buy |
2,203,500
+2,158,269
| +4,772% | +$120M | 0.07% | 227 |
|
|
2014
Q2 | $2.55M | Hold |
45,231
| – | – | ﹤0.01% | 728 |
|
|
2014
Q1 | $2.32M | Sell |
45,231
-238,518
| -84% | -$12.1M | ﹤0.01% | 702 |
|
|
2013
Q4 | $15M | Sell |
283,749
-4,110,306
| -94% | -$202M | 0.01% | 512 |
|
|
2013
Q3 | $197M | Sell |
4,394,055
-1,141,722
| -21% | -$50.6M | 0.12% | 169 |
|
|
2013
Q2 | $229M | Buy |
+5,535,777
| New | +$242M | 0.15% | 141 |
|
Other funds holding ABBV
VCM
VPM
Massachusetts Financial Services's ABBV Position: Q1 2026 in Review
Massachusetts Financial Services reduced its AbbVie (ABBV) stake by 15% in Q1 2026, selling an estimated $212M and leaving 5,610,330 shares worth $1.23B. The position accounts for 0.41% of the portfolio, ranked #68.
Massachusetts Financial Services first reported a position in ABBV in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.94B in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Massachusetts Financial Services held 5,610,330 shares of AbbVie worth $1.23B as of Q1 2026.
- Massachusetts Financial Services sold 953,928 AbbVie shares in Q1 2026, an estimated $212M.
- AbbVie made up 0.41% of Massachusetts Financial Services's portfolio in Q1 2026, its #68 holding.
- Massachusetts Financial Services first reported a position in AbbVie in Q2 2013 and has held it in 39 quarters since.
- Massachusetts Financial Services's AbbVie position peaked at $1.94B in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.